Search

everythinglearnresearchcommunity

for

Search:↓

The FDA approved the first gene therapy for a blood disorder after overcoming early challenges and demonstrating patient benefits.

Iontophoresis with growth factors safely and effectively promotes hair regrowth without discomfort.

Exosomes may help with hair growth and scar healing, but more research is needed.

PRP is popular for hair restoration but needs better research methods to confirm its effectiveness and safety.

PRP shows promise but lacks consistent evidence and regulation.

Finasteride and Dutasteride can improve hair growth in male baldness but may cause temporary sexual dysfunction and possibly affect fertility.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Platelet Rich Plasma (PRP) injections can improve hair count, thickness, and strength in people with androgenic alopecia.

Nanotechnology shows promise for better chronic wound healing but needs more research.

The document concludes that understanding genetic mutations in the PI3K-AKT-mTOR pathway can lead to better diagnosis and treatment for certain genetic skin disorders.

Metformin, a diabetes drug, may help prevent and treat various cancers, but more research is needed.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

The document concludes that diagnosing and treating Interstitial Pneumonia with Autoimmune Features (IPAF) is challenging, needs a multidisciplinary approach, and further research for better diagnostic criteria and treatments. It also emphasizes regular checks for Connective Tissue Disease symptoms in all patients with Interstitial Lung Disease.

QR 678 and QR 678 Neo are safe and promote hair growth, potentially helping chemotherapy-induced hair loss.

Some small molecule antivirals show promise against COVID-19, but more research is needed to understand and improve them.

Regenerative cellular therapies show promise for treating non-scarring hair loss but need more research.

Some traditional Chinese medicines may have anti-aging benefits and could help with hair growth, but more research is needed.

Regenerative medicine shows promise for improving hair and skin but needs more research for standard use.

Cannabidiol shows promise as an effective treatment for acne.

JAK inhibitors show promise for treating various skin diseases.

PRP use in skin care and plastic surgery is growing, especially in the U.S. and Italy.

High-dose finasteride may help treat glioblastoma but needs localized delivery for effectiveness.

Non-scarring alopecia in females affects emotional well-being and requires accurate diagnosis and personalized treatment.

Low-level laser therapy is the most supported treatment for hair loss, but other methods show promise.

Spironolactone effectively treats female acne with few side effects.

Eribulin-based chemotherapy is more effective and has fewer side effects for advanced triple-negative breast cancer.

Using existing drugs for new purposes could be a cost-effective way to treat chest pain and non-clogged heart arteries, with some drugs for lung blood pressure showing promise but needing more testing.

IVL-DrugFluidic® can mass-produce high-quality, long-acting injectable drug microspheres, improving patient compliance and reducing side effects.

Topical minoxidil is the best-supported treatment for female hair loss, but personalized plans are needed.

Stem cell treatments show promise for hair loss but need more research.